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Introduction
Chronic opiate addicts, either when maintained on opiate agonists 
or when abstinent (Weiss, 1982), have increased craving, prefer-
ence for, and intake of sugary foodstuffs (Kolarzyk et al., 2005a; 
Morabia et al., 1989; Nolan and Scagnelli, 2007; Zador et al., 
1996), with added sugar contributing ~30% of total calorific intake 
(Saeland et al., 2011). These preference and dietary effects are 
known to be linked to opiate intake (Titsas and Ferguson, 2002), 
and are also seen in experimental animals (Bodnar, 2004; Kelley et 
al., 2002). The increased intake of processed sugars in opiate 
addicts may be linked to the reward associated with sucrose 
(Langleben et al., 2012), rather than other factors, as there are no 
clear relationships between, for example, socioeconomic status 
and diet in these individuals (Morabia et al., 1989; Zador et al., 
1996). The majority of studies find that this dietary change does 
not significantly affect body mass index (BMI), as this is in the 
normal range (Forrester et al., 2005; Kolarzyk et al., 2005b; 
Morabia et al., 1989) (but see also (Nolan and Scagnelli, 2007)). 
The principal result of this increased sugar intake in opiate addicts, 
and also in those on opiate-substitution therapy, such as methadone 
or buprenorphine, is that they typically have poor oral and dental 
health, compared to non-intravenous drug users, or non-addicts 
(Reece, 2007; Robinson et al., 2005; Titsas and Ferguson, 2002).
In non-drug-using populations, opiates are well recognised to 
exert potent effects on appetite and eating behaviour (Yeomans 
and Gray, 1997); similar effects are seen in experimental animals 
(Yeomans and Gray, 2002). Opiate antagonists generally decrease 
food intake (Bertino et al., 1991), sweet preference (Fantino et al., 
1986) and measures of food palatability in humans (Yeomans and 
Gray, 2002), although this is not a universal finding (Hetherington 
et al., 1991).
The consistent effects of opiate antagonists on palatability in 
healthy humans do not, however, extend to other aspects of taste 
perception, such as intensity (strength of perceived taste) or 
threshold measurements. Perceived intensity (ratings of “salti-
ness” or “sweetness”) is unaffected by opiate antagonists (Bertino 
et al., 1991; Hetherington et al., 1991; Scinska et al., 2000; 
Yeomans and Gray, 1996). The cortical area associated with taste 
intensity is the insular cortex (Grabenhorst and Rolls, 2008). 
Opiate agonists and antagonists modulate  
taste perception in opiate-maintained  
and recently detoxified subjects
Amy Green1, Arun Kaul2, Jacinta O’Shea2, Ekta Sharma2,  
Lisa Bennett3, Emma L Mullings4, Marcus R Munafò4,  
David J Nutt1,5, Jan K Melichar1,2,3 and Lucy F Donaldson3
Abstract
Heroin addicts consume large quantities of refined sugars. This study investigated the effect of opiate use and antagonism on sweet taste in opiate-
maintained drug users and detoxified former chronic opiate users, using a within-subject design.
 Seven opiate users received methadone and seven buprenorphine maintenance. Six detoxified subjects received naltrexone. Sucrose recognition 
thresholds and measurements of pleasantness and intensity were determined before and four hours after 1) a single dose of methadone or buprenorphine 
or 2) naltrexone. Control data were taken from a cohort of healthy volunteers including smokers.
 All measures of sweet and salt taste perception were significantly greater in opiate users and recently detoxified subjects compared to control 
subjects, with the exception of sweet pleasantness, which returned to control level after detoxification. Acute methadone administration reduced salt 
thresholds and unpleasantness to control levels. Increased sweet thresholds and salt unpleasantness in detoxified subjects were reversed by acute 
opioid antagonism, returning to control levels. These results suggest that opiate use and antagonism alters taste perception. Some of the alterations 
reverse on detoxification (sweet pleasantness), and others can be reversed by opioid antagonism (sweet threshold, salt unpleasantness). Changes in 
taste perception may underlie altered consumption of refined sugars in opiate users.
Keywords
Human, methadone, naltrexone, taste
1Psychopharmacology Unit, University of Bristol, Bristol, UK 
2 Bristol Specialist Drug and Alcohol Service (BSDAS), Avon and Wiltshire 
Partnership NHS Trust, Bristol, UK
3 Schools of Physiology and Pharmacology, University of Bristol, Bristol, 
UK 
4Experimental Psychology, University of Bristol, Bristol, UK 
5Neuropsychopharmacology Unit, Division of Experimental Medicine, 
Imperial College London, London, UK
Corresponding author:
Jan K Melichar, Psychopharmacology Unit, Oakfield House, Faculty of 
Medicine and Dentistry, University of Bristol, Bristol, BS8 2BN, UK.
Email: Jan.Melichar@bris.ac.uk
472567 JOP27310.1177/0269881112472567Journal of PsychopharmacologyGreen et al.
2013
Original Paper
266 Journal of Psychopharmacology 27(3)
There is little published evidence that insular cortex function is 
changed by chronic opiate use in humans, although there is greater 
neuronal activation of this area immediately following opiate 
detoxification in rats, and on acute morphine challenge (Taracha 
et al., 2008). Taste thresholds are similarly unaffected by opiate 
antagonists in healthy individuals (Arbisi et al., 1999).
Opioid peptides have not been detected in taste cells or asso-
ciated nerve fibres in humans (Astback et al., 1995; Astback et al., 
1997; Kusakabe et al., 1998), but encephalin has been localised 
to rodent taste cells (Yoshie et al., 1993). In rodents, opioid 
peptides and mu (Ding et al., 1998; Mansour et al., 1995) and 
delta receptors (Ichikawa et al., 2005) are found throughout the 
ascending gustatory pathways, particularly in the nucleus tractus 
solitarius (NTS), and opiates in the NTS reduce gustatory input 
in approximately 25% of gustatory neurons (Li et al., 2003). 
This inhibition is not related to any taste modality. Thus, there 
are other potential central nervous system (CNS) sites where 
exogenous opioids could directly modulate aspects of taste 
perception such as threshold and intensity.
Areas of the brain involved in mediating opiate effects on 
eating behaviour and hedonic measures of rewarding taste (for 
example, sweet (Rolls and Grabenhorst, 2008)), such as orbito-
frontal cortex, are known to be dysfunctional in opiate, cocaine 
and alcohol users (Ma et al., 2010; Volkow and Fowler, 2000). 
We hypothesised that ratings for a pleasant taste (sweet), but not 
an unpleasant taste (salt) would be altered in participants on opi-
ate-maintenance therapy (OMT). As these neuronal changes are 
also known to be maintained for some time following detoxifica-
tion from alcohol addiction (Volkow and Fowler, 2000), we also 
hypothesised that acutely detoxified opiate users would show 
similar changes in taste pleasantness perception, i.e. that any 
changes seen in opiate users would be similar to those seen in 
acutely detoxified ex-opiate users.
This study therefore addressed the following hypotheses: that 
opiate maintenance therapy would be associated with a change in 
sweet, but not salt taste threshold, intensity and pleasantness; that 
opiate detoxification would not, in the short term, affect the 
opiate-related change in sweet taste observed in opiate users; that 
acute administration of an opiate antagonist would reverse these 
changes, and that acute administration of an opiate antagonist in 
healthy controls would alter taste pleasantness, but not intensity or 
thresholds.
Materials and methods
Four participant groups were recruited to address the study aims.
1) Opiate addicts (drug-user group) receiving mainte-
nance-opiate treatment with either methadone or 
buprenorphine,
2) recently detoxified former opiate addicts (detox group),
3) healthy volunteers given intravenous (i.v.) naloxone 
(naloxone control group),
4) a control group of healthy individuals, including some 
smokers.
Local research ethics committees (National Health Service 
(NHS) Local Research Ethics Committee, Groups 1 and 2, and 
University of Bristol Faculty Research Ethics Committee, Groups 
3 and 4) approved all procedures and protocols. After full explana-
tion of the study aims and procedures, all participants gave written 
informed consent. Participants in Groups 1, 2 and 4 were given a 
£10 voucher for a local supermarket in recompense for their time.
The general characteristics of the participants are summarised 
in Table 1.
Different protocols were used for each part of the study, as 
detailed below.
Within-subject studies on the effect of chronic  
opiate use on taste threshold, intensity and 
pleasantness perception (in drug-user group)
Recruitment and selection. Participants were recruited from 
patients attending Bristol Specialist Drug and Alcohol Service 
(BSDAS), the NHS substance misuse service in Bristol. Participants 
were selected based on a diagnosis of opiate dependence, and 
attended the service for heroin substitution with either methadone 
or buprenorphine (see Table 1 for details).
Inclusion/exclusion criteria. All patients attending for main-
tenance therapy were approached with a view to recruitment. 
Participants were excluded on initial screening on the following 
criteria: abnormal findings of clinical significance on medical or 
psychiatric history (excluding opiate dependence); high caffeine 
intake (greater than six cups of coffee/day); illicit drug use (except 
prescribed opiates); excessive alcohol intake (greater than 30 
units/week); heavy smoking (greater than 20 cigarettes/day); 
pregnancy; current prescribed psychotropic drugs; high scores for 
anxiety and/or depression (measured by Speilberger’s Anxiety 
Inventory and Beck’s Depression Inventory (Beck et al., 1961; 
Spielberger et al., 1983)). A laboratory urine sample was collected 
from each participant, and those who had evidence of heroin, 
Table 1. Participant characteristics.
Study group (n) Drug Male:Female Age range Smoking status % Sweet liker % Salt disliker
Drug users (14) methadone  6:1 30 (21–38)  5/13 83  75
 buprenophine  4:3 86 100
Detox (6) naltrexone  4:2 35 (27–43)  4/6 67  83
Naloxone (10) naloxone  4:6 32 (23–40  0/10 60  90
Controls (65) — 25:40 30 (19–63) 24/65 70a  85a
aOne participant rated 1 M sucrose as exactly zero (neutral) on first exposure to sweet, and two participants rated 1 M NaCl as zero on first exposure to salt, and therefore 
could not be classified as either ‘liker’ or ‘disliker’. Note that there is a significantly higher proportion of women in the control group than in the experimental groups. 
Median and range are shown for ages in each group.
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cocaine, benzodiazepines or cannabis use in the preceding seven 
days were also excluded from analysis. During the period of the 
study (January–December 2007) several researchers were present 
on the clinic (AG, ES, AK, JO’S), for one day per week. When 
researchers were present on the clinic, all patients attending for 
OMT were approached for recruitment to the study. Twenty 
patients agreed to take part in the study in the recruitment period 
and attended for both taste-testing sessions. Of these 20, six par-
ticipants were later excluded, largely as a result of other drug or 
alcohol use in the time between the baseline and subsequent taste 
tests. All included subjects refrained from alcohol intake for at 
least 12 hours prior to testing and refrained from caffeine con-
sumption on the day of the test.
Taste recognition threshold was determined in all participants 
before and four hours after maintenance-opiate administration, at 
a dose commensurate with each participant’s usual maintenance 
requirements.
Taste threshold was determined at each test by construction of 
taste psychophysical functions for sweet and salt taste recogni-
tion (Heath et al., 2006; Prutkin et al., 1999) (Figure 1). 
Participants were informed as to the taste modality they would 
receive at each point in the procedure (Pilková et al., 1991). 
Sucrose and sodium chloride (NaCl) tastes were tested separately 
and the order of testing was counterbalanced across participants. 
A range of concentrations was made by serial dilution from 1 M 
stock of either sucrose or NaCl. Solutions, in an overall concen-
tration range from 1 M to 1 mM, separated by one-quarter log 
concentration steps, were applied to the tip of the tongue using a 
saturated cotton bud for each application. The different concen-
trations were presented in a pseudorandom order; if a participant 
easily recognised a concentration, the following concentration 
presented would be a lower concentration; if the taste was not 
recognised then a higher concentration would be presented. Once 
concentrations were determined at which recognition occurred at 
every presentation (100% recognition, five of five presentations) 
or did not occur (0% recognition), concentrations between these 
two were presented. Each concentration was presented five times. 
Participants rinsed the mouth between each presentation, and the 
inter-stimulus interval was approximately 30 seconds. The par-
ticipant responses were then used to generate a psychophysical 
taste function using a sigmoidal curve fit of the stimulus-response 
curves constrained at 0 and 5 (Figure 1A). Recognition threshold 
was determined as the concentration at which the participant 
could detect the taste 50% of the time (Figure 1) (Heath et al., 
2006; Mullings et al., 2009).
Taste pleasantness and intensity were determined using gener-
alised Labeled Magnitude Scales (gLMS) (Bartoshuk et al., 2004; 
Mullings et al., 2009). For pleasantness/unpleasantness, a quasi-
logarithmic 170 mm positive/negative scale (85 mm positive, 85 
mm negative) was used, anchored at “most pleasant imaginable” 
and “least pleasant imaginable”, with “neutral” as a midpoint 
(Figure 1B). Unpleasant taste is indicated by a negative score on 
this scale. For intensity a 150 mm scale was used, anchored at 
“barely detectable” and “strongest imaginable sensation”. The 
descriptors on both scales were placed at the same relative inter-
vals as those originally reported for a 100-unit gLMS (Bartoshuk 
et al., 2004), so descriptors on figures are comparable to those 
from other studies using a similar gLMS. The values presented are 
converted to a 100 mm scale (0–100 for intensity, and −50 to +50 
for pleasantness, so a positive point 70 mm on the pleasantness 
scale would be represented as 70/85*100 = 82) to allow compari-
son to literature values.
Use of the gLMS was carefully explained to participants, 
but they received no prior training session in its use because 
of time constraints. Participants were asked to swill 5 mL of 
a suprathreshold salt or sweet (1 M) solution around their 
mouth for 10 seconds and then rate pleasantness and intensi-
ties on the scales. Sweet and salt “likers” and “dislikers” in 
each group were classified by a positive or negative score on 
first exposure to 1 M sucrose or salt solution (Looy and 
Weingarten, 1992).
Figure 1. A. Psychophysical taste functions for a participant in the 
detox group. The curves shown are before (filled circles) and after 
naltrexone (open circles, dotted line). The horizontal and vertical 
dotted lines show the values determined for threshold (i.e. correct 
identification of the stimulus as sweet in 2.5 of five presentations). 
Note that the symbols for the values after naltrexone have been shifted 
slightly upward to prevent overlap with the filled symbols. Note also 
that the x-axis is reversed, i.e. lowered threshold is indicated by a 
leftward shift of the function.
B. The positive/negative generalised Labeled Magnitude Scale used to 
assess pleasantness. The central dotted line represents the ‘neutral’ 
point, neither pleasant nor unpleasant. Solutions were rated according 
to the anchors shown and expressed as a positive (arrow) or negative 
(arrowhead) distance on the line, and then converted to a 100-point 
scale as detailed in the methods.
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Sweet taste was hypothesised to be the taste that would be 
modulated by opioidergic systems, and salt was used as a control 
taste modality, as it is transduced by a separate population of taste 
cells (Type III cells as opposed to Type II cells (Roper, 2007)). 
Only two taste modalities were tested in all participants because 
of time constraints for testing, particularly in participants prior to 
their maintenance-opiate administration.
Within-subject studies on the effect of opiate 
antagonism in recently detoxified ex-opiate 
user on taste perception (detox group)
Recruitment and selection. All participants were in-patients 
from the dedicated NHS substance misuse inpatient unit in Bristol 
(Table 1). They were selected for recruitment interview on the 
basis of a diagnosis of opiate dependence and were inpatients for 
opiate detoxification and possible naltrexone treatment. Partici-
pants were completely abstinent from all opiates for at least one 
week (confirmed by urine analysis), and were abstinent from alco-
hol intake for greater than one week prior to the test day. The 
inpatient service admits ~two to three people per week for detoxi-
fication. During the period of the study (July–December 2007) a 
researcher (AG) was present on the ward and interviewed all 
admitted patients with an appropriate diagnosis about recruitment 
to the trial. During that time, only eight patients were willing to be 
recruited to the trial, despite a larger number of patients 
approached. Two of these participants were subsequently excluded 
as a result of incomplete data sets. The number of patients going 
through the detoxification programme who are subsequently pre-
scribed naltrexone as outpatients are a very small number of the 
total number going through detoxification, hence the relatively 
low numbers recruited to this arm of the study. This is primarily 
because of patient resistance to being prescribed any medications 
following detoxification.
Exclusion/inclusion criteria. The criteria for exclusion from 
the study are as detailed for Group 1. One data set was incomplete 
for a participant who developed acute symptoms of naltrexone 
treatment (nausea and vomiting) in whom taste testing was not 
possible.
None of the detox participants had been previously treated 
with naltrexone. A single oral dose of 25 mg naltrexone is rou-
tine clinical practice on the ward for patients opting to move 
onto naltrexone therapy after detoxification, so this intervention 
conformed to the usual clinical treatment in this unit. None 
of the patients went into acute withdrawal after naltrexone 
administration.
Taste threshold, pleasantness and intensity were determined in 
these participants before and four hours after a single 25 mg dose 
of naltrexone using the same methods as described for Group 1.
Within-subjects placebo-controlled crossover 
study on the effect of endogenous opiates on 
taste perception (naloxone group)
Healthy volunteers were recruited from within the University of 
Bristol (Table 1). Subjects were all non-smokers who met the 
overall inclusion criteria detailed for Group 1 (other than opiate 
dependence).
In the naloxone group, taste threshold, intensity and pleasant-
ness were determined before and 10, 25 and 45 minutes after an 
intravenous (i.v.) injection of 13 µg/kg naloxone (made up to 5 
mL in saline) or 5 mL saline (both administered to each participant 
at a single visit), through an indwelling Venflon (20G) inserted 
into the antecubital fossa. The drugs were delivered double blind, 
and the order of saline/naloxone delivery counter-balanced for 
the participants. This concentration of naloxone has been 
demonstrated to occupy 50% of CNS opioid receptors in healthy 
individuals (Melichar et al., 2003).
Control group
Taste perception was also measured using the same techniques 
in the same time period in a group of healthy controls. These 
included some non-abstinent smoking participants (all ≥ five 
cigarettes per day, smoking first cigarette within one hour of 
waking), and the proportion of smokers in the control group was 
equivalent to those in the drug-user and detox groups (Table 1). 
Despite a larger age range in the control group, the age distribu-
tion was not different between control and experimental groups. 
The data collected from smokers were derived from a different 
previously published study (Mullings et al., 2009). Data from 
otherwise healthy normal weight (BMI 18–25), smoking and 
non-smoking participants were derived from our anonymised 
database of taste thresholds, liking and intensity, some of which 
have been included in previous studies (Donaldson et al., 2009; 
Heath et al., 2006; Mullings et al., 2009). Some of the data from 
drug-user and detox groups have been published in abstract form 
(Green et al., 2008; Kaul et al., 2008).
Methodological consideration of taste recognition 
determination. This method was chosen over more widely 
used two- or three-way forced-choice methods as it permits very 
rapid testing and generation of full psychometric functions. The 
method is based on physiological definition of sensory threshold, 
as being the stimulus intensity that evokes a response at 50% of 
presentations (Kandel et al., 2000). Rapid testing is required when 
working with opiate addicts prior to administration of their main-
tenance dose of either buprenorphine or methadone. Full psycho-
metric functions (Figure 1) can yield information not found with 
methods that determine only threshold, such as taste acuity (slope 
of the function). In a direct comparison between this method and 
a two-way forced choice regional threshold determination 
(McMahon et al., 2001), we found no differences in threshold 
values (Bennett and Donaldson, 2008, unpublished observations). 
In addition, this method of regional threshold determination has 
the advantage that it reduces the possibility of potential confounds 
arising from spatial differences in taste thresholds in the mouth. 
The tip of the tongue also displays the smallest differences in salt 
and sweet thresholds between men and women, as previously 
demonstrated (Sato et al., 2002).
Data analysis
Data were analysed using GraphPad Prism version 4.00 for 
Macintosh (GraphPad Software, San Diego, CA, USA, www.
graphpad.com). Group comparisons were made using analysis of 
variance (ANOVA), and post-hoc Bonferroni tests were used, as all 
data sets were Gaussian. Paired two-group comparisons were made 
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(paired t tests) to compare means before and after an intervention, 
i.e. within the drug-user and detox groups. Repeated-measures 
ANOVA was used for comparison of data from participants given 
i.v. naloxone/saline. Two-tailed Spearman rank order correlations 
were used to determine relationships between variables.
Results
Alteration in taste threshold, intensity and 
pleasantness in participants on OMT and  
relationship to opiate dose
The overall pattern of taste changes in opiate addicts under treat-
ment was not significantly different for participants receiving 
methadone or buprenorphine. The findings for these two groups 
are therefore presented together.
Based on previously published data on the dietary shift toward 
processed sugars in opiate users (Saeland et al., 2011; Zador et al., 
1996) and opiate involvement in palatability and pleasantness of 
food in opiate users (Kolarzyk et al., 2005b; Morabia et al., 1989; 
Titsas and Ferguson, 2002), we hypothesised that the pleasantness 
of sucrose would be higher in the drug-user group, and our find-
ings supported this hypothesis (Figure 2A). There was no differ-
ence in the absolute numbers of sweet “likers” versus “dislikers” 
in the control group compared to drug users before opiate admin-
istration (Table 1; Fisher’s exact test p=0.33). In addition, both 
sweet taste recognition thresholds (Figure 2B) and intensity of the 
1 M sucrose solution were significantly raised in drug users com-
pared to controls (Figure 2C). There were no differences in these 
measures between the methadone- and buprenorphine-maintained 
participants. The administration of maintenance opiate had no 
effect on any measure of sweet taste perception.
The effect of opiate maintenance on salt taste measures was 
different from the effect on sweet taste. Control participants gen-
erally perceived the salt solution tested as being “slightly” to 
“moderately” unpleasant (Figure 3A), and participants on OMT 
rated the salt solution as being significantly more unpleasant 
(“very unpleasant”) than the control group before their mainte-
nance dose. As with sweet liking, there was no difference in the 
proportions of salt dislikers (before opiate) between groups (Table 
1; p=1). The administration of opiate resulted in a small, non-sig-
nificant decrease in the perceived unpleasantness of salt in these 
participants (Figure 3A) (this was largely attributable to one par-
ticipant in whom pleasantness shifted from −77 mm to +77 mm). 
The recognition threshold for salt was also significantly raised in 
these participants, and, in contrast to the observations for sucrose 
taste, administration of opiate resulted in a significant reduction in 
threshold, effectively returning recognition threshold to control 
levels in these participants (Figure 3B).
The intensity of the 1 M salt solution was significantly raised 
in opiate-maintained participants, and this was also unaffected by 
opiate administration (Figure 3C).
The maintenance dose of methadone reflects the degree of 
opiate tolerance of a patient, inasmuch as this is the opiate dose 
required to evoke an effect, i.e. to prevent withdrawal. To 
address the possible relationships between different aspects of 
taste perception, and this readout of opiate tolerance, we exam-
ined the correlation between different taste measures (pleasant-
ness, recognition threshold and intensity) before and after the 
acute methadone administration, and methadone-maintenance 
dose. Buprenorphine doses used for maintenance are all 
supramaximal, as this drug is a partial rather than a full µ opiate 
receptor agonist. Data were therefore available only for the 
seven participants who were maintained on methadone.
There was no significant correlation between sweet taste intensity 
and dose of methadone either before (Spearman r = −0.75, p=0.053; 
Figure 4A) or after methadone administration (Spearman r = −0.02, 
p=0.97; Figure 4B), although intensity before methadone and dose 
bordered on significance. Sweet taste threshold before methadone was 
also not correlated with methadone dose (r =0.15, p=0.75; Figure 4C), 
whereas after methadone, when receptor occupancy would be 
increased, the sweet taste thresholds were significantly correlated with 
the methadone dose (Spearman r = 0.81, p=0.027; Figure 4D). There 
were no significant correlations between sweet taste pleasantness, nor 
between any measure of salt taste and methadone dose (not shown).
Figure 2. Effect of opiate maintenance and opiate-maintenance therapy 
(OMT) on sweet taste perception in opiate users.
A. Opiate-maintained drug users rated 1 M sucrose as significantly more pleasant than 
controls. Before and after refer to ratings taken before and four hours after OMT.
B. Opiate-maintained drug users had significantly higher sweet recognition thresh-
olds than controls, and OMT had no effect on threshold. Note that the right-hand 
y axis shows the concentration of sucrose represented as approximate teaspoons 
of sugar/mug, i.e. 0.3 M is equivalent to ~ six teaspoons in a 200 mL mug, for 
comparison.
C. Opiate-maintained drug users rated 1 M sucrose as significantly stronger 
than controls. OMT had no effect on intensity. Data are mean + SEM, *p<0.05; 
***p<0.001. 
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Alteration of taste perception after 
detoxification, and the effect of acute opiate 
antagonist administration
There were no differences in sweet pleasantness ratings in detoxi-
fied participants, either before or after acute naltrexone adminis-
tration (Figure 5A), or compared to the control group, indicating 
that detoxification had reversed the changes in pleasantness seen 
in opiate users. As with the drug-user group, there was no differ-
ence in the proportion of sweet likers between the two groups 
(Table 1; p=1). Variability of pleasantness increased after naltrex-
one as a result of one participant whose pleasantness ratings 
increased from −50 to +78 mm. In comparison to drug users, 
detoxified participants had lower pleasantness ratings, but equiva-
lent intensities and recognition thresholds to those seen in drug 
users (Figure 5B and 5C). Sucrose recognition thresholds were 
higher in detoxified participants than in controls (Figure 5B), and 
acute administration of naltrexone reversed these to the same level 
as in the control group. Naltrexone administration had no effect on 
sucrose intensity ratings (Figure 5C).
In contrast, the pattern for salt taste unpleasantness ratings in 
detox participants, immediately after detoxification, was similar 
to that seen in drug users (Figure 6A) in that salt continued to be 
rated as being significantly more unpleasant, and more intense 
after detoxification, compared to control groups. Thresholds 
were also still raised after detoxification. There was no difference 
in the proportion of salt dislikers between the two groups 
(Table 1; p=0.57). No measure of salt taste was affected by 
naltrexone administration (Figures 6A–6C), although unpleas-
antness was non-significantly reduced.
Acute administration of opiate antagonist in 
healthy individuals
Naloxone had no effect on taste perception, either on threshold, 
intensity or pleasantness in healthy non-smoking controls 
(Table 2).
Discussion
These findings demonstrate that people on opiate maintenance for 
the treatment of addiction have disrupted measures of taste per-
ception that are in part reversed in recently detoxified former opi-
ate users, when compared to controls.
Opiate users perceive sucrose as being more pleasant than 
controls, whereas in detoxified ex-users pleasantness ratings 
are no different from controls, indicating that detoxification can 
reverse the changes in sweet pleasantness seen in opiate users. 
Neither OMT nor naltrexone administration themselves had an 
effect on sweet pleasantness. These findings indicate that 
altered pleasantness for sucrose, which may underpin the 
altered processed carbohydrate intake in opiate users, is rapidly 
changed after a short period of detoxification.
Previous observations of sweet taste pleasantness in heroin-
using addicts have shown an increase in perceived pleasantness 
(Perl et al., 1997). Detoxified addicts or those maintained on 
methadone did not have altered pleasantness ratings compared 
to controls (Bogucka-Bonikowska et al., 2002; Perl et al., 1997). 
In both these previous studies, the values obtained for the con-
trol group pleasantness ratings using the linear visual analogue 
scale (VAS) were higher than those in our study. Our use of the 
positive/negative gLMS may therefore have served to discrimi-
nate more effectively between the different groups, who are very 
likely to have different sensory perceptual experiences. This is a 
strength of this scale compared to linear VAS (Bartoshuk et al., 
2004).
Our data suggest that one week of detoxification might begin 
to reset enhanced pleasantness perception in drug users, but it 
would be important to determine the long-term effect of detoxifi-
cation on taste pleasantness in order to define whether the reversal 
in sweet taste perception is maintained, whether it is sufficient to 
influence dietary carbohydrate content, or if changes in threshold, 
intensity or salt taste are also needed to affect dietary choice, and, 
finally, whether these changes could be attributable to altered cor-
tical function.
Figure 3. Effect of opiate maintenance and opiate maintenance therapy 
(OMT) on salt taste perception in opiate users.
A. Opiate-maintained drug users rated 1 M NaCl as significantly more unpleasant 
than controls and OMT returned unpleasantness toward control values (NS).
B. Opiate-maintained drug users had significantly higher salt recognition thresh-
olds, and OMT lowered thresholds to the same level as controls.
C. Opiate-maintained drug users rated 1 M NaCl as significantly stronger than 
controls, and OMT had no effect on the intensity ratings.
Data are mean + SEM, **p<0.01; ***p<0.0001; NS: not significant.
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The observations in both the experimental groups, particularly 
in comparison to each other, should be treated with some caution 
because of low numbers, particularly in the detox group. 
Recruitment in this group was particularly problematic as a result 
of the wish amongst detoxified addicts as well as their support 
workers to avoid any drug treatment, leading to an avoidance of 
opting for naltrexone treatment in inpatients.
There were other limitations to this study that also should be 
acknowledged, such as failure of drug users to commit to two test 
visits, or illicit drug use between taste tests. We acknowledge that 
the drug treatments cannot be compared to a placebo control, nor 
blinded, as for ethical reasons we could not alter the planned clini-
cal treatment of these patients. The control group was taken from 
our previous studies as being representative of smoking status and 
age, and is large, and as such may confound the data. There are 
also proportionally more women than men in this group compared 
to the experimental groups.
Contrary to our original hypothesis, and in contrast to the 
effects on sweet taste, changes were also observed for salt taste, in 
that both experimental groups perceived salt as being more 
unpleasant than controls, prior to any acute drug administration.
Naltrexone administration had no significant effect on sweet 
pleasantness or salt unpleasantness in the small group of detoxi-
fied addicts in this study; the slight tendency for this to change is 
attributable to one participant in whom, for example, sweet rat-
ings increased from −50 to +78 mm. This is in contrast to a large 
number of studies in healthy volunteers where naltrexone reduced 
food palatability, intake and sweet pleasantness ratings (see 
introduction and references in (Yeomans and Gray, 2002) but also 
(Hetherington et al., 1991; Scinska et al., 2000)). Depot naltrex-
one also reduced both ‘liking’ and a measure of sweet intensity in 
abstinent opiate addicts (Langleben et al., 2012). This latter find-
ing suggests that longer-term, or higher dose, naltrexone therapy 
may be required to see any effect on taste perception, or that opi-
ate antagonist effects are different in detoxified former drug users 
than in other populations. The test dose of naltrexone used in this 
study is 25 mg, as opposed to the 50 mg used in most other stud-
ies, as a result of the need to adhere to usual clinical practice in our 
clinic.
Finally, naloxone had no effect on pleasantness of sweet taste in 
healthy participants, despite published reports that naloxone has 
similar effects on taste hedonics and food palatability to naltrexone 
Figure 4. Relationships between different measures of taste perception and opiate tolerance.
A. The intensity of 1 M sucrose was inversely related to the opiate tolerance, as estimated by the required dose of methadone. This relationship did not quite reach 
significance (Spearman r = −0.75, p=0.053).
B. The intensity of 1 M sucrose was not related to opiate tolerance after methadone administration (r = −0.02, p=0.97).
C. Sucrose recognition threshold was not correlated with opiate tolerance before opiate administration (r=0.15, p=0.75).
D. After opiate administration, when opiate receptors are occupied, the sucrose recognition threshold was significantly correlated with methadone dose (r = 0.81, 
p=0.027). Dotted lines show mean intensities (A and B) and thresholds (C and D) in the controls for comparison.
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Figure 5. Effect of opiate antagonist on sweet taste in detoxified 
opiate users.
A. Detoxified opiate users rated 1 M sucrose as being only as pleasant as control 
participants did, and the acute administration of opiate had a slight but non-
significant effect on this. Before and after refer to ratings taken before and four 
hours after administration of naltrexone.
B. Sweet taste thresholds were higher in detoxified opiate users than in controls, 
and were acutely lowered by naltrexone administration.
C. Detoxified opiate users rated 1 M sucrose as significantly more intense than 
controls, and the acute administration of naltrexone had no effect on intensity 
ratings. Data are mean + SEM; *p<0.05; **p<0.01; ***p<0.001.
Figure 6. Effect of opiate antagonist on salt taste in detoxified opiate 
users.
A. Detoxified opiate users rated 1 M NaCl as being more unpleasant 
than the controls. Although acute administration of naltrexone reduced 
unpleasantness, this was not significantly different from either before 
naltrexone, or control.
B. Salt taste recognition thresholds were higher in detoxified opiate users than in 
controls, and were unaffected by naltrexone administration.
C. Detoxified opiate users rated 1 M NaCl as significantly more intense than 
controls, and the acute administration of naltrexone had no effect on intensity 
ratings. Data are mean + SEM; *p<0.05; **p<0.01; ***p<0.001.
Table 2. Taste measures in healthy participants before and after i.v. naloxone.
Time Pleasantness (mm) Threshold (mM) Intensity (mm)
Sweet Salty Sweet Salty Sweet Salty
 saline naloxone saline naloxone saline naloxone saline naloxone saline naloxone saline naloxone
before 9±14 5±16 –22±9 –19±10 30±24 36±30 52±73 44±36 43±9 39±16 53±15 40±19
10 minutes 9±17 6±17 –26±12 –20±7 36±32 33±29 38±38 51±52 41±17 39±16 57±14 48±13
25 minutes 8±19 6±15 –25±8 –21±10 46±43 36±22 42±41 36±33 41±16 37±16 53±14 49±19
45 minutes 9±17 6±15 –25±6 –24±11 36±31 34±24 36±36 37±31 41±13 36±17 53±13 51±16
i.v.: intravenous. Data shown are means ±SD in mM (thresholds), and mm (intensity and pleasantness). Negative pleasantness values indicate unpleasant taste. 
The ratings for intensity and pleasantness are given in mm as determined from the generalised Labeled Magnitude Scales (gLMS). For reference the following mm 
measurements relate to the given descriptors on the scales: intensity (100 mm scale: moderate = 17mm, strong = 35 mm), pleasantness/unpleasantness (positive/
negative 100 mm scale, midpoint neutral (0 mm), moderately pleasant/unpleasant = ±8 mm, pleasant/unpleasant = ±17 mm, very pleasant/unpleasant = 26 mm).
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(Drewnowski et al., 1995; Komorowski and Komorowska, 1986; 
Trenchard and Silverstone, 1983). Thus, although naltrexone and 
naloxone may not be directly comparable as a result of different 
routes of administration and dose, our data disagree with the 
majority of literature data on the effects of opiate antagonism on 
sweet taste pleasantness. Like naltrexone, the dose of naloxone, 
while being a concentration that results in occupation of 50% of 
opiate receptors (Melichar et al., 2003), is at the lower end of lit-
erature values, and the lack of effect seen here may be a combina-
tion of lower dose and shorter time scale of study (< one hour).
No study has previously reported taste threshold data in opiate 
users or detoxified addicts. We found that sucrose thresholds were 
significantly increased in opiate users to a level equivalent to 
approximately three to four teaspoons of sugar in a mug — 
interestingly, this is the minimum level of sweetness reported by 
recovering drug users to be preferred in their drinks (Robinson 
et al., 2005). This might suggest that the raised threshold in this 
group contributes to the increase in sucrose added to beverages, as 
it may necessary to add sugar to drinks to achieve a suprathresh-
old level of sweetness. Opiate administration had no effect on 
sucrose thresholds. In contrast, the acute administration of opiate 
reduced the higher salt recognition threshold seen in drug users to 
control levels. We suggest that a reduced threshold after opiate 
administration would, at the least, enable recognition of lower 
levels of salt in food, and the combination of these shifts in thresh-
old may contribute to a move away from salty and toward sweet 
foodstuffs in these individuals, to reach a concentration of sugar 
that is detectable in the diet.
Surprisingly, in the detox group naltrexone did reduce the 
increased sweet threshold back to control levels. The significant 
effect of naltrexone on sucrose recognition thresholds in recently 
detoxified users may indicate that the opioidergic receptor sys-
tems involved in sweet taste recognition are not initially affected 
by detoxification, but may be acutely “reset” by naltrexone. This 
could be interpreted as indicating that opiate receptors in brain 
areas involved in sweet taste recognition threshold might behave 
differently from those elsewhere in the brain, as most altered 
opioidergic systems in chronic drug users are not thought to be 
acutely reset by antagonist treatment. This suggests that naltrexone 
treatment after detoxification might have an adjunct effect of 
helping reverse some of the gustatory changes that might con-
tribute to altered eating behaviour in opiate addicts. The blunted 
thresholds might be attributable to altered processing in other 
gustatory areas, for example, gustatory inputs into the nucleus of 
the solitary tract, which are known to be modulated by opiates in 
experimental rodents (Li et al., 2003).
Intensity of both sweet and salt taste was increased in drug 
users as well as detox groups and was unaffected by either 
opiate or naltrexone. This is in contrast to previous studies 
where intensity was not different in methadone-maintained 
men (Bogucka-Bonikowska et al., 2002), and after depot 
naltrexone, when “sweetness” was reduced, albeit at only two 
sucrose concentrations (Langleben et al., 2012).
There are two areas of interest that should be highlighted in the 
findings — firstly that OMT did not increase the pleasantness of 
all tastes, but only sucrose and not salt, in which pleasantness 
decreased, and secondly, that increased pleasantness of sucrose in 
opiate users is also associated with increased thresholds and inten-
sities. While it may seem counterintuitive that these very different 
measures of taste perception are all altered in opiate users, it is 
known that these different aspects of taste are not directly related 
(Keast and Roper, 2007), and indeed are encoded in different 
areas of the brain. For example, umami (the taste of glutamate) 
thresholds are raised, but suprathreshold intensity measures were 
unaltered in obese women (Pepino et al., 2010). Alterations in 
pleasantness and intensity suggest that there is altered central 
processing of taste in opiate users, and that some of this might be 
acutely reversed on detoxification. Pleasantness is represented in 
the orbitofrontal and insular cortices (Rolls and Grabenhorst, 2008; 
Small et al., 2003), whereas intensity is represented in insular 
cortex and amygdala (Grigson, 2002; Small et al., 2003). This is 
consistent with the known disruption seen in these areas in opiate 
users (Daglish et al., 2003; Volkow and Fowler, 2000).
The observations of relationships between methadone dose 
and taste threshold and intensity are possibly suggestive of a 
contribution of the opiate receptor state in these participants to 
these sensory measures, although interpretation is, of course, 
limited by low participant numbers. However, we could speculate 
that the more tolerant users are to methadone (as indicated by their 
higher dose of methadone), the more blunted their sweet taste 
threshold, and the less intense they find a highly concentrated 
sucrose solution. In more general terms relating to addictions, 
alcoholics show altered sweet taste perception, particularly in 
relation to sweet preference, a measure that may indicate the 
efficacy of naltrexone for the treatment of alcoholism (Garbutt 
et al., 2009; Laaksonen et al., 2011). Accumulating evidence 
therefore suggests that sweet taste hedonic measures and, as we 
have shown, possibly other perceptual measures such as intensity 
and thresholds may represent indicators of opiate tolerance and 
appropriate methadone-maintenance regimens.
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